Alongside the conventional markers for ovarian cancer detection (CA-125 and HE4), other predictive biomarkers have been used, including circulating tumor DNA (ctDNA), DNA methylation, and tumor-specific autoantibodies [53]. The gene discussed is MUC16; the disease is neoplasm.